ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » South Dakota » Hematology Oncology

Top Hematology Oncology Prescribers in South Dakota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RICHARD CONKLIN MD

Hematology Oncology

4,831

$1.26M

456
408 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

11%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 14%

$260
Average prescription price

Avg: $382

MICHAEL MCHALE MD

Hematology Oncology

2,059

$765K

313
284 are 65+

4%
patients receiving schedule two controlled substances

Avg: 10%

5%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 14%

$372
Average prescription price

Avg: $382

MARK HUBER M.D.

Hematology Oncology

1,745

$683K

223
188 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

17%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 14%

$392
Average prescription price

Avg: $382

KELLY MCCAUL M.D.

Hematology Oncology

1,475

$1.72M

157
123 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 14%

$1168
Average prescription price

Avg: $382

MICHAEL KEPPEN M.D.

Hematology Oncology

1,349

$467K

198
178 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

14%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 14%

$346
Average prescription price

Avg: $382

KAMRAN DARABI MD

Hematology Oncology

1,248

$512K

146
130 are 65+

16%
patients receiving schedule two controlled substances

Avg: 10%

10%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 14%

$410
Average prescription price

Avg: $382

ELIE DIB MD

Hematology Oncology

1,238

$437K

159
148 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 14%

$353
Average prescription price

Avg: $382

ADDISON TOLENTINO M.D.

Hematology Oncology

1,138

$260K

159
139 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

11%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 14%

$228
Average prescription price

Avg: $382

MARY LEE VILLANUEVA M.D.

Hematology Oncology

840

$160K

119
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 14%

$191
Average prescription price

Avg: $382

MAX FARVER MD

Hematology Oncology

642

$291K

97
87 are 65+

12%
patients receiving schedule two controlled substances

Avg: 10%

16%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 14%

$453
Average prescription price

Avg: $382

RAMAKRISHNAN PARAMESWARAN M.D.

Hematology Oncology

621

$148K

65
49 are 65+

17%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 14%

$239
Average prescription price

Avg: $382

ANWARUL HAQ M.D.

Hematology Oncology

552

$63.8K

104
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 8%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

5%
prescriptions for brand name drugs

Avg: 14%

$116
Average prescription price

Avg: $382

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank